Binghua Li

2.3k total citations
73 papers, 1.5k citations indexed

About

Binghua Li is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Binghua Li has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in Binghua Li's work include Cancer, Hypoxia, and Metabolism (11 papers), Cancer Research and Treatments (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Binghua Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Cancer Research and Treatments (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Binghua Li collaborates with scholars based in China, United States and Spain. Binghua Li's co-authors include Decai Yu, Tiancheng Xu, Jiwu Wei, Gang Meng, Yajuan Cao, Yitao Ding, Liyuan Qian, Yan Chen, Beicheng Sun and Lixiao Zhou and has published in prestigious journals such as Cell, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Binghua Li

67 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binghua Li China 23 844 370 203 188 163 73 1.5k
Zhenguo Zhao China 21 1.0k 1.2× 509 1.4× 162 0.8× 98 0.5× 90 0.6× 79 1.8k
Mikiko Suzuki Japan 26 1.4k 1.7× 204 0.6× 195 1.0× 212 1.1× 176 1.1× 73 2.3k
Xiaolong Liu China 20 835 1.0× 252 0.7× 257 1.3× 76 0.4× 264 1.6× 45 1.6k
Lin Cheng China 22 847 1.0× 259 0.7× 364 1.8× 82 0.4× 143 0.9× 72 1.5k
David Gilot France 25 1.0k 1.2× 347 0.9× 307 1.5× 140 0.7× 303 1.9× 54 2.2k
Dong Zhang China 25 973 1.2× 432 1.2× 289 1.4× 110 0.6× 182 1.1× 74 1.9k
Joo Mi Yi South Korea 26 1.3k 1.5× 488 1.3× 459 2.3× 145 0.8× 158 1.0× 79 2.0k
Suresh B. Pakala United States 28 1.2k 1.4× 333 0.9× 497 2.4× 102 0.5× 87 0.5× 58 1.8k
Ewa Forma Poland 22 924 1.1× 382 1.0× 209 1.0× 84 0.4× 221 1.4× 75 1.5k
Haixin Li China 23 708 0.8× 289 0.8× 220 1.1× 157 0.8× 64 0.4× 99 1.5k

Countries citing papers authored by Binghua Li

Since Specialization
Citations

This map shows the geographic impact of Binghua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binghua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binghua Li more than expected).

Fields of papers citing papers by Binghua Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binghua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binghua Li. The network helps show where Binghua Li may publish in the future.

Co-authorship network of co-authors of Binghua Li

This figure shows the co-authorship network connecting the top 25 collaborators of Binghua Li. A scholar is included among the top collaborators of Binghua Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binghua Li. Binghua Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yingying, Jingjing Zhang, Fan Tu, et al.. (2025). Association between metabolic dysfunction associated steatotic liver disease and gallstones in the US population using propensity score matching. Scientific Reports. 15(1). 910–910. 2 indexed citations
2.
Gao, X. Y., Hui Wang, Binghua Li, et al.. (2025). Assessing the Needs of Patients with Cancer and Healthcare Professionals for a Digital Pain Management System: A Qualitative Study. Patient Preference and Adherence. Volume 19. 605–614.
3.
Shen, Yumeng, Weijun Zhao, Yuyuan Chen, et al.. (2025). PLAGL2 promotes HCC progression by recruiting tumour‐associated macrophages via CCL2/CCR2 signalling. British Journal of Pharmacology.
4.
Wang, Ye, Yanjun Lu, Yanchao Xu, et al.. (2024). β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma. Cancer Research. 84(10). 1643–1658. 15 indexed citations
5.
Xu, Tiancheng, Lei Yu, Yajuan Cao, et al.. (2024). Apolipoprotein A1-encoding recombinant adenovirus remodels cholesterol metabolism in tumors and the tumor microenvironment to inhibit hepatocellular carcinoma. Translational research. 275. 18–31. 5 indexed citations
6.
Xu, Xian, Beibei Shen, Jianping Wang, et al.. (2024). Using RNA-Seq Analysis to Select Key Genes Related to Seed Dormancy in ALS-Inhibiting Resistant Descurainia sophia with Pro-197-Thr Mutation. Plants. 13(16). 2305–2305. 1 indexed citations
7.
Cui, Xiaohan, Zhu Xu, Zechuan Zhang, et al.. (2024). Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. Journal of Hepatology. 81(5). 847–861. 28 indexed citations
8.
Zhu, Mingming, Dongjun Luo, Huihui Chen, et al.. (2024). TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma. Oncogene. 43(9). 682–692. 13 indexed citations
9.
Su, Ke, Binghua Li, Ye Wang, et al.. (2023). Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study. BMC Cancer. 23(1). 1081–1081. 4 indexed citations
10.
Jiang, Xiang, Jin Peng, Yuanyuan Xie, et al.. (2023). Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function. Cell Death and Differentiation. 30(8). 1931–1942. 6 indexed citations
11.
Li, Yunzheng, Binghua Li, Yanchao Xu, et al.. (2022). GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors. Cancer Research. 82(18). 3223–3235. 48 indexed citations
13.
Jiang, Bo, Xiaozhi Zhao, Wei Chen, et al.. (2022). Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nature Communications. 13(1). 4141–4141. 27 indexed citations
14.
Wang, Meina, Lulu Li, Binghua Li, et al.. (2020). DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene. 39(33). 5507–5519. 17 indexed citations
15.
Jiang, Bo, Wei Chen, Haixiang Qin, et al.. (2019). TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma. Cancer Letters. 449. 76–86. 19 indexed citations
16.
Cao, Yajuan, Binghua Li, Xianbiao Shi, et al.. (2018). Effects of GLS1 on the epithelial-mesenchymal transition of hepatocellular carcinoma in vitro and i n vivo. Translational Cancer Research. 7(1). 97–108. 2 indexed citations
17.
18.
Li, Binghua. (2007). Establishment of A Regeneration System from the Stem of Petunia hybrida Vilm. Zhongnan Linye Keji Daxue xuebao. 1 indexed citations
19.
Li, Binghua, Xinran Liu, Junkai Fan, et al.. (2006). A survivin‐mediated oncolytic adenovirus induces non‐apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. The Journal of Gene Medicine. 8(10). 1232–1242. 26 indexed citations
20.
Li, Binghua. (1987). An analysis of the karyotype of Amolops wuyiensis. Asian Herpetological Research. 64. 42–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026